The China Mail - US authorizes first condom for use in anal sex

USD -
AED 3.67302
AFN 70.000054
ALL 84.349866
AMD 383.820075
ANG 1.789699
AOA 917.000301
ARS 1371.506083
AUD 1.556275
AWG 1.8025
AZN 1.703435
BAM 1.708921
BBD 2.018218
BDT 122.195767
BGN 1.713604
BHD 0.37697
BIF 2942.5
BMD 1
BND 1.297101
BOB 6.907097
BRL 5.5997
BSD 0.999672
BTN 87.54407
BWP 13.649927
BYN 3.271194
BYR 19600
BZD 2.00782
CAD 1.387145
CDF 2890.000253
CHF 0.816505
CLF 0.024812
CLP 973.379906
CNY 7.20045
CNH 7.22053
COP 4186.71
CRC 505.122436
CUC 1
CUP 26.5
CVE 95.950165
CZK 21.513299
DJF 177.719816
DKK 6.53923
DOP 60.999825
DZD 130.941154
EGP 48.629701
ERN 15
ETB 138.189175
EUR 0.876255
FJD 2.27485
FKP 0.756365
GBP 0.759525
GEL 2.698038
GGP 0.756365
GHS 10.436401
GIP 0.756365
GMD 72.498365
GNF 8674.999742
GTQ 7.676882
GYD 209.126455
HKD 7.849915
HNL 26.35009
HRK 6.601301
HTG 131.169313
HUF 350.169974
IDR 16518.5
ILS 3.415745
IMP 0.756365
INR 87.457501
IQD 1310
IRR 42112.500092
ISK 124.602851
JEP 0.756365
JMD 159.943729
JOD 0.709006
JPY 150.527503
KES 129.199706
KGS 87.449577
KHR 4014.999697
KMF 431.499735
KPW 899.980278
KRW 1405.630155
KWD 0.30613
KYD 0.832958
KZT 539.837043
LAK 21579.999767
LBP 89549.999753
LKR 302.068634
LRD 200.99981
LSL 18.01024
LTL 2.95274
LVL 0.60489
LYD 5.414981
MAD 9.104004
MDL 17.212259
MGA 4430.000287
MKD 53.918885
MMK 2098.469766
MNT 3591.435698
MOP 8.082308
MRU 39.819718
MUR 46.830536
MVR 15.402246
MWK 1736.497294
MXN 18.94327
MYR 4.279754
MZN 63.960199
NAD 18.009881
NGN 1531.319772
NIO 36.749828
NOK 10.349185
NPR 140.070338
NZD 1.704086
OMR 0.384499
PAB 0.999585
PEN 3.568999
PGK 4.13025
PHP 58.266023
PKR 283.250566
PLN 3.750685
PYG 7486.402062
QAR 3.64075
RON 4.448096
RSD 102.677999
RUB 80.198911
RWF 1440
SAR 3.751287
SBD 8.244163
SCR 14.684383
SDG 600.502706
SEK 9.811485
SGD 1.298465
SHP 0.785843
SLE 23.000372
SLL 20969.503947
SOS 571.502829
SRD 36.815499
STD 20697.981008
STN 21.925
SVC 8.746368
SYP 13001.991551
SZL 18.010433
THB 32.828967
TJS 9.425981
TMT 3.51
TND 2.880275
TOP 2.342102
TRY 40.669799
TTD 6.786518
TWD 29.953303
TZS 2565.000042
UAH 41.696586
UGX 3583.302388
UYU 40.0886
UZS 12604.999953
VES 123.721575
VND 26212
VUV 120.138643
WST 2.771841
XAF 573.151008
XAG 0.027402
XAU 0.000304
XCD 2.70255
XCG 1.80154
XDR 0.69341
XOF 566.497322
XPF 104.924934
YER 240.649911
ZAR 18.2951
ZMK 9001.203721
ZMW 22.965115
ZWL 321.999592
  • SCU

    0.0000

    12.72

    0%

  • RBGPF

    0.5200

    74.94

    +0.69%

  • CMSC

    0.2500

    22.85

    +1.09%

  • NGG

    0.2000

    70.39

    +0.28%

  • BCC

    -1.0800

    83.81

    -1.29%

  • SCS

    0.0000

    10.33

    0%

  • RIO

    0.2800

    59.77

    +0.47%

  • JRI

    0.0200

    13.13

    +0.15%

  • RYCEF

    1.0800

    14.18

    +7.62%

  • RELX

    0.1100

    51.89

    +0.21%

  • CMSD

    0.2100

    23.27

    +0.9%

  • GSK

    -1.8200

    37.15

    -4.9%

  • BCE

    -0.2000

    23.33

    -0.86%

  • VOD

    -0.2500

    10.81

    -2.31%

  • BTI

    0.5200

    53.68

    +0.97%

  • BP

    -0.1000

    32.15

    -0.31%

  • AZN

    -3.5000

    73.09

    -4.79%

US authorizes first condom for use in anal sex
US authorizes first condom for use in anal sex

US authorizes first condom for use in anal sex

The US Food and Drug Administration (FDA) on Wednesday authorized the first condom for use during anal intercourse, in what was hailed as a victory for sexual health by experts.

Text size:

Although people already use condoms for anal sex -- as is recommended by health agencies including the Centers for Disease Control and Prevention (CDC) -- regulators across the world had only previously allowed companies to officially market their products as "safe and effective" for vaginal use.

Sexual health advocates considered this an unmet public health need since unprotected anal intercourse carries the greatest risk of HIV transmission via sexual exposure, with one study finding that 69 percent of men who have sex with men would use condoms more frequently if they were FDA-indicated.

Wednesday's authorization of Global Protection Corp's One Male Condom follows a clinical trial involving more than 500 people, carried out by Emory University.

"The FDA's authorization of a condom that is specifically indicated, evaluated and labeled for anal intercourse may improve the likelihood of condom use during anal intercourse," said agency scientist Courtney Lias in a statement.

The condom is also indicated to prevent sexually transmitted infections -- and as a contraceptive -- during vaginal sex.

"We want people to have lots of sex -- but we also want them to be empowered and informed," said Davin Wedel, president of Global Protection Corp, which makes the condom brand that is available in 54 sizes, and incorporates a paper template to help each user find the right size.

The clinical trial involved 252 men who have sex with men and 252 men who have sex with women, aged between 18 and 54.

The FDA had said it would accept a five percent failure rate, which previous trials had failed to accomplish. The limit was easily surpassed in the new study, with the failure rate 0.68 percent for anal and 1.89 percent for vaginal intercourse.

The researchers behind the study, which was published in The Lancet's eClinicalMedicine, said one of the reasons the trial succeeded where others failed in the past was likely due to the provision of lubricant and inclusion of instructions on how to use the product.

Lubricant reduces friction, which in turn causes condom failure from slippage and breakage.

Another reason could be that participants were asked to keep mobile phone-based daily diaries, whereas past trials had asked volunteers to recall failure events up to several months later.

Monica Gandhi, an infectious disease doctor and medical director of an HIV clinic in San Francisco, welcomed the finding.

"The important thing about condoms is they don't just prevent HIV, but they prevent gonorrhea, chlamydia and syphilis," she told AFP, adding it was surprising that such an authorization had taken so long to achieve.

In its statement, the FDA said the green light could pave the way for more makers to apply for similar authorization if they show equivalent results.

D.Pan--ThChM